The latest business and people happenings, and COVID-19 response, from around the industry.
PRISYM ID has made changes to its senior leadership team. Life sciences and technology veteran Richard Adams has joined as Chief Executive Officer, and Lauren Patterson has been appointed Chief Financial Officer.
Advarra announced the appointment of Gadi Saarony as Chief Executive Officer.
MMS Holdings Inc. announced the addition of Kelly Vaillant as Director, Global Transparency Strategy and Compliance.
SGS Clinical Pharmacology Unit
SGS is supporting ZNA Stuivenberg Hospital, Antwerp in its fight against the COVID-19 pandemic by offering the use of its Clinical Pharmacology Unit, within the hospital, equipped with 88 beds. SGS has also donated Personal Protective Equipment, including 1,100 masks and 21,000 gloves.
WCG is providing access to a web resource, WCG COVID-19 Patient Insights Resource Center, dedicated to representing the voice, perspective, and needs of patients and study participants in clinical trials during the COVID-19 pandemic.
BioIVT announced the opening of its new blood donor center on the Tufts University campus in Medford, MA to support academic and pharmaceutical researchers involved in COVID-19, cell and gene therapy research.
Sharp Clinical has confirmed that it is involved in supporting six clinical trials related to COVID-19.
Syneos Health, supported by the Association of Clinical Research Organizations, has announced a volunteer program to enable clinically qualified employees to address the UK government’s call for volunteers to support COVID-19 testing.
CROMSOURCE announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company.
PPD, Inc. has been named by IDG’s CIO as a 2020 CIO 100 Awards honoree.
TrialScope’s “Real Patient Stories: The Trials of Finding Clinical Trials,” has won a Silver award in the WEGO Health Patient-Choice Awards for Most Authentic Use of Patients in a Marketing Campaign.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.